NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice
In Brief: House Cuts NCI Rescission To $7.73 Million; Weinhuse, Ultmann New ACCR, ASCO Presidents
ACCC Committee Hears Alternative Ways To Do Clinical Trials In Community
AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement
ACS Urged To Put More Resources Into Psychosocial Research
Laertrile Clinical Study Provides Solid Evidence: It Is Useless
Trending Stories
- Franco Muggia, former head of CTEP and NYU cancer center, dies at 85
- House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99M
House joins Senate in rejecting Trump’s proposed 40% NIH cuts - Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing
- Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”